We help you join the dots...

RAS LSS is a niche strategy consultancy serving the global life sciences sector

 
 

Starting with Information Services in 2014, RAS LSS has evolved into a boutique healthcare consulting group. We offer a niche portfolio of Strategy Support and Information Services to Pharmaceutical and Medical Device Companies, throughout the product life-cycle.

We elucidate and contextualize current and future market complexities. Leveraging our collective intelligence, we strive to help our clients succeed via

  • Best In Class Situation Analysis
  • Competitively Differentiated Strategy
With an outreach across mature and emerging markets, we go the extra mile to create fresh perspectives for our clients in their mission to reduce the global burden of disease.


We have put in the hours and the sweat to be credible…


Latest Blogs

July 18, 2019
marijuna

From ‘Weed rush’ to a ‘Pot of Gold’ – Medical Marijuana and the Pharma Industry

    The story back then… Cannabis’ (Marijuana) use as medicine dates back to 4000 BC in China. During the 19th century and till early 20th century, marijuana was used globally, to treat various illnesses such as migraine, neuropathic pain, musculoskeletal pain and in childbirth.2 In Canada, cannabis was added […]
July 18, 2019
value-based care

Healthcare: Shift from Volume to Value

Healthcare is an expanding and complex industry. The ageing population, higher prevalence of chronic diseases, advances in digital technologies, highly efficacious and expensive drugs have led to an increase in the healthcare demand and expenditures. The global health care spending projected at $ 10.05 Trillion by 2022 represents 2018-2022 CAGR […]
July 12, 2019
Brexit

Deal or No Deal Brexit? – What’s Next for the Pharmaceutical Industry

It’s been almost 3 years since the British voted 52-48% to leave the EU on 23rd June 2016.12  Given the lack of clarity and ensuing uncertainty, the pharmaceutical companies have been planning for a worst-case scenario i.e. no-deal. We will look at the most important (subjectively assessed) implications of a […]
July 10, 2019
3D Printing

Body Printing or Printing Your Body: A Short Introduction To Bioprinting

Biofabrication can be defined as the production of complex living and non-living biological products from raw materials such as living cells, molecules, extracellular matrices, and biomaterials. – Mironov et al., 2015. First things first…What´s 3D printing? The standard two-dimensional (2D) printing is the act of depositing ink on a 2D […]
June 28, 2019
Clinical_Research

Oncology Clinical Research – A holy Grail or a Mine Field?

Oncology R&D investment has been consistently increasing. A case in point: Of the 65000 trials registered on clinicatrials.gov, there are approx. 19000 product related ongoing trials. It´s noteworthy that a trial´s probability of success hasn´t increased over the years i.e. most of these trials face a higher risk of failure […]
June 17, 2019
Rx Usage

Medicine Use and Spending in the USA

The latest report from the IQVIA™ Institute for Human Data Science presents the 2018 Medicines Use and Spending in the U.S. The report provides extensive metrics on drug usage and its cost to the US Healthcare system. We discuss some of the interesting findings of this report. 2018 witnessed a […]